These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 18975307

  • 1. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
    Sawaji Y, Hynes J, Vincent T, Saklatvala J.
    Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
    [Abstract] [Full Text] [Related]

  • 2. Effect of Phellodendron amurense in protecting human osteoarthritic cartilage and chondrocytes.
    Kim JH, Huh JE, Baek YH, Lee JD, Choi DY, Park DS.
    J Ethnopharmacol; 2011 Mar 24; 134(2):234-42. PubMed ID: 21182922
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2.
    Lemke AK, Sandy JD, Voigt H, Dreier R, Lee JH, Grodzinsky AJ, Mentlein R, Fay J, Schünke M, Kurz B.
    Cell Tissue Res; 2010 Apr 24; 340(1):179-88. PubMed ID: 20217136
    [Abstract] [Full Text] [Related]

  • 4. Effects of transforming growth factor-beta on aggrecanase production and proteoglycan degradation by human chondrocytes in vitro.
    Moulharat N, Lesur C, Thomas M, Rolland-Valognes G, Pastoureau P, Anract P, De Ceuninck F, Sabatini M.
    Osteoarthritis Cartilage; 2004 Apr 24; 12(4):296-305. PubMed ID: 15023381
    [Abstract] [Full Text] [Related]

  • 5. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, Caterson B.
    Biochem J; 1999 Nov 15; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [Abstract] [Full Text] [Related]

  • 6. Evidence of a novel aggrecan-degrading activity in cartilage: Studies of mice deficient in both ADAMTS-4 and ADAMTS-5.
    Rogerson FM, Stanton H, East CJ, Golub SB, Tutolo L, Farmer PJ, Fosang AJ.
    Arthritis Rheum; 2008 Jun 15; 58(6):1664-73. PubMed ID: 18512787
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system.
    Powell AJ, Little CB, Hughes CE.
    Arthritis Rheum; 2007 Sep 15; 56(9):3010-9. PubMed ID: 17763444
    [Abstract] [Full Text] [Related]

  • 10. Potential role of hyaluronic acid on bone in osteoarthritis: matrix metalloproteinases, aggrecanases, and RANKL expression are partially prevented by hyaluronic acid in interleukin 1-stimulated osteoblasts.
    Mladenovic Z, Saurel AS, Berenbaum F, Jacques C.
    J Rheumatol; 2014 May 15; 41(5):945-54. PubMed ID: 24737908
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
    Chockalingam PS, Zeng W, Morris EA, Flannery CR.
    Arthritis Rheum; 2004 Sep 15; 50(9):2839-48. PubMed ID: 15457452
    [Abstract] [Full Text] [Related]

  • 13. Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes.
    Yatabe T, Mochizuki S, Takizawa M, Chijiiwa M, Okada A, Kimura T, Fujita Y, Matsumoto H, Toyama Y, Okada Y.
    Ann Rheum Dis; 2009 Jun 15; 68(6):1051-8. PubMed ID: 18662930
    [Abstract] [Full Text] [Related]

  • 14. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
    Little CB, Hughes CE, Curtis CL, Jones SA, Caterson B, Flannery CR.
    Arthritis Rheum; 2002 Jan 15; 46(1):124-9. PubMed ID: 11817583
    [Abstract] [Full Text] [Related]

  • 15. Natural chondroitin sulphates increase aggregation of proteoglycan complexes and decrease ADAMTS-5 expression in interleukin 1 beta-treated chondrocytes.
    Tahiri K, Korwin-Zmijowska C, Richette P, Héraud F, Chevalier X, Savouret JF, Corvol MT.
    Ann Rheum Dis; 2008 May 15; 67(5):696-702. PubMed ID: 17901089
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-4 antagonizes oncostatin M and transforming growth factor beta-induced responses in articular chondrocytes.
    El Mabrouk M, Qureshi HY, Li WQ, Sylvester J, Zafarullah M.
    J Cell Biochem; 2008 Feb 01; 103(2):588-97. PubMed ID: 17546624
    [Abstract] [Full Text] [Related]

  • 17. Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2.
    Hui W, Barksby HE, Young DA, Cawston TE, McKie N, Rowan AD.
    Ann Rheum Dis; 2005 Nov 01; 64(11):1624-32. PubMed ID: 15883123
    [Abstract] [Full Text] [Related]

  • 18. The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities.
    Moncada-Pazos A, Obaya AJ, Viloria CG, López-Otín C, Cal S.
    J Mol Med (Berl); 2011 Jun 01; 89(6):611-9. PubMed ID: 21365186
    [Abstract] [Full Text] [Related]

  • 19. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
    Tortorella MD, Malfait AM, Deccico C, Arner E.
    Osteoarthritis Cartilage; 2001 Aug 01; 9(6):539-52. PubMed ID: 11520168
    [Abstract] [Full Text] [Related]

  • 20. Activation of cartilage matrix metalloproteinases by activated protein C.
    Jackson MT, Smith MM, Smith SM, Jackson CJ, Xue M, Little CB.
    Arthritis Rheum; 2009 Mar 01; 60(3):780-91. PubMed ID: 19248107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.